Health

Caspian Therapeutics Launches with $50M for Diabetes Research

Updated 2026-09-09 11:10 UTC 1 source Neutral

Caspian Therapeutics has launched with a $50 million investment to develop menin inhibitors for diabetes and other cardiometabolic diseases. The company aims to explore new treatment approaches.

Coverage timeline — 1 article

STAT News

STAT+: Leukemia drug data suggested a different way to treat diabetes. A new biotech will test that idea

Caspian Therapeutics, is launching with $50 million in financing to develop menin inhibitors for diabetes and other cardiometabolic diseases.

2026-09-09 11:00 UTC